Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

Vilniaus universiteto ligonine Santaros klinikos VšĮ

Lithuania Santariskiu G. 1, Vilniaus M. Sav., 08660 Vilnius, Lithuania

About the sponsor

The clinical research activity centres on cutaneous malignant melanoma, with attention to patients requiring treatment after radical surgery for high-risk disease. The therapeutic interest is focused on adjuvant immunotherapy in advanced-stage melanoma, including stage IIb, III, and IV disease.

  • Cutaneous malignant melanoma
  • High-risk melanoma after surgery
  • Adjuvant immunotherapy
  • Advanced-stage melanoma

Research activity is linked to a multi-site collaboration network across Europe, reflecting involvement in oncology care for patients with aggressive melanoma.

About Specializations

Vilniaus universiteto ligonine Santaros klinikos VšĮ runs clinical trials in conditions such as Malignant melanoma, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Malignant melanoma

Recruiting

Study on Short vs. Long Immunotherapy with Pembrolizumab and Nivolumab for Patients with High-Risk Skin Melanoma After Surgery

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:North Estonia Medical Centre Foundation

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.